Harada, Hiroaki http://orcid.org/0000-0001-5566-9973
Shoda, Hirofumi http://orcid.org/0000-0002-1536-0303
Tsuchiya, Haruka http://orcid.org/0000-0002-2114-7656
Misaki, Makoto http://orcid.org/0000-0002-5385-657X
Sawada, Takayuki http://orcid.org/0009-0005-5920-183X
Fujio, Keishi http://orcid.org/0000-0001-7276-5254
Article History
Received: 12 November 2023
Accepted: 27 January 2024
First Online: 8 March 2024
Declarations
:
: KF receives speaking fees and research support from Eli Lilly and Company; HT receives speaking fees from Eli Lilly and Company; and the other authors have no conflict of interest to declare.
: Written informed consent was obtained from the patients or their relatives for publication of this article. Our review processes were approved by the Research Ethics Committee of the University of Tokyo (approval number 2431, final version approved on 21 December 2022).